Granahan Investment Management’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-527,147
Closed -$6.94M 182
2024
Q4
$6.94M Sell
527,147
-211,105
-29% -$2.78M 0.29% 88
2024
Q3
$8.28M Sell
738,252
-243,797
-25% -$2.73M 0.33% 93
2024
Q2
$10.6M Sell
982,049
-64,796
-6% -$697K 0.42% 77
2024
Q1
$15.6M Sell
1,046,845
-103,921
-9% -$1.55M 0.55% 59
2023
Q4
$20.8M Buy
1,150,766
+211,557
+23% +$3.83M 0.69% 45
2023
Q3
$16.3M Buy
939,209
+128,852
+16% +$2.23M 0.58% 51
2023
Q2
$14.7M Buy
810,357
+291,392
+56% +$5.28M 0.45% 65
2023
Q1
$13.8M Buy
518,965
+13,781
+3% +$367K 0.42% 71
2022
Q4
$9.77M Buy
505,184
+124,091
+33% +$2.4M 0.3% 93
2022
Q3
$7.96M Sell
381,093
-148,718
-28% -$3.11M 0.26% 102
2022
Q2
$4.24M Buy
529,811
+40,477
+8% +$324K 0.14% 127
2022
Q1
$3.43M Buy
489,334
+216,149
+79% +$1.52M 0.09% 151
2021
Q4
$3.69M Buy
+273,185
New +$3.69M 0.08% 163